Mediphage Bioceuticals is a genetic medicine company developing safe, effective, and accessible cures for chronic and infectious diseases. Mediphage’s proprietary msDNA allows for redosable and titratable gene delivery, and unlike conventional viral and non-viral vectors, it does not compromise safety for effectiveness. As a versatile platform technology, msDNA is being employed in internal programs for Stargardt disease and COVID-19 and in external partnerships to evaluate msDNA in Hemophilia A, Dravet Syndrome, CNS, oncology and immunotherapy.

Mediphage Bioceuticals Inc. logo



Event details

Date: September 14 - 16, 2020

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences


16 in total